Article
Predictors of response to immunotherapy in colorectal cancer
26 Jun 2024
Abstract excerpt
Colorectal cancer (CRC) is a major cause of cancer-related deaths globally. While treatment advancements have improved survival rates, primarily through targeted therapies based on KRAS, NRAS, and BRAF mutations, personalized treatment strategies for CRC remain limited. Immunotherapy, mainly immune checkpoint blockade, has shown efficacy in various cancers but is effective in only a small subset of patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
